Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Zydus Pharms Usa Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ZYDUS PHARMS USA, and what generic and branded alternatives to ZYDUS PHARMS USA drugs are available?

ZYDUS PHARMS USA has fifty-seven approved drugs.

There are twenty-one tentative approvals on ZYDUS PHARMS USA drugs.

Summary for Zydus Pharms Usa

US Patents:	0
Tradenames:	48
Ingredients:	48
NDAs:	57

Drugs and US Patents for Zydus Pharms Usa

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms Usa	LAMOTRIGINE	lamotrigine	TABLET;ORAL	077633-002	Jan 27, 2009		RX	No	No		⤷ Try it Free				⤷ Try it Free
Zydus Pharms Usa Inc	PRAMIPEXOLE DIHYDROCHLORIDE	pramipexole dihydrochloride	TABLET;ORAL	078920-001	Jul 6, 2010	AB	RX	No	No		⤷ Try it Free				⤷ Try it Free
Zydus Pharms Usa	SIMVASTATIN	simvastatin	TABLET;ORAL	077837-004	Dec 20, 2006	AB	RX	No	No		⤷ Try it Free				⤷ Try it Free
Zydus Pharms Usa Inc	DIVALPROEX SODIUM	divalproex sodium	TABLET, DELAYED RELEASE;ORAL	077100-002	Mar 5, 2009	AB	RX	No	No		⤷ Try it Free				⤷ Try it Free
Zydus Pharms Usa Inc	DIPYRIDAMOLE	dipyridamole	TABLET;ORAL	040874-003	Jan 28, 2008	AB	RX	No	No		⤷ Try it Free				⤷ Try it Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for ZYDUS PHARMS USA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

McKinsey

AstraZeneca

Johnson and Johnson

Medtronic

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.